Nanobiotix S.A.

NBTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$38.89+1.30%

2026-08-03

Financials

Valuation Metrics

Nanobiotix S.A.'s Market Cap is $1.89B. At end of 2025 it was $239M. Ranked #2091 of 3,112 in US market (top 67%), #806 of 1,445 on NASDAQ (top 56%), #141 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 52%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.89B	US#2,091/3,112 Sec#141/269
Revenue	$34M	US#2,886/3,112 Sec#165/269
Net Income	$-27M	US—/3,112 Sec—/269
Total Assets	$80M	US#3,046/3,112 Sec#267/269
Net Assets	$-99M	US#3,013/3,112 Sec#265/269
Value
P/S	56.12x	US#2,883/3,112 Sec#170/269
FCF Yield	-2.04%	US—/3,112 Sec—/269
Profitability
ROA	-34.13%	US#2,896/3,112 Sec#173/269
Op. Margin	-36.49%	US#2,751/3,112 Sec#111/269
Financial Health
Total Debt	$112M	US#2,352/3,112 Sec#114/269
FCF	$-39M	US#2,442/3,112 Sec#109/269
Cash	$62M	US#2,488/3,112 Sec#215/269
Current Ratio	1.09x	US#2,153/3,112 Sec#257/269
Performance
1Y Return	471.91%	US#17/3,112 Sec#9/269
1M Return	1.28%	US#1,460/3,112 Sec#61/269
From 52W High	-31.94%	US#2,246/3,112 Sec#170/269
1Y MDD	-50.25%	US#2,412/3,112 Sec#187/269
Trading
Volume	150,884 shares	US#2,789/3,112 Sec#258/269
Trading Value	$6M	US#2,612/3,112 Sec#214/269
Per Share
EPS	$-2.08	US—/3,112 Sec—/269